Recital 5, Regulation (EU) 2021/457

In forcesince 13 Jan 2021

The withdrawal of the United Kingdom from the Union would, in the absence of a derogation from the applicable rules, thus have the effect that the unique identifiers must be decommissioned for medicinal products intended to be distributed in the United Kingdom.